Tutorials
BSP:B1NT34 (Germany)  
BioNTech SE logo

BioNTech SE

R$ 101.42 (-6.1%) Aug 9
P/E:
2.69
P/B:
2.21
Market Cap:
R$ 24.61B ($ 4.80B)
Enterprise V:
R$ 147.65B ($ 28.81B)
Volume:
14.76K
Avg Vol (2M):
9.87K
Also Trade In:
Volume:
14.76K
Market Cap R$:
24.61B
Market Cap $:
4.80B
PE Ratio:
2.69
Avg Vol (2-Month):
9.87K
Enterprise Value R$:
147.65B
Enterprise Value $:
28.81B
PB Ratio:
2.21
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Name Current Vs Industry Vs History
Cash-To-Debt 33.15
Equity-to-Asset 0.78
Debt-to-Equity 0.01
Debt-to-EBITDA 0.01
Interest Coverage 1167.27
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.3
Distress
Grey
Safe
Beneish M-Score 5.75
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 27.43
9-Day RSI 37.06
14-Day RSI 42.98
6-1 Month Momentum % -1.09
12-1 Month Momentum % -61.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.05
Quick Ratio 4.93
Cash Ratio 1.6
Days Inventory 26.42
Days Sales Outstanding 140.93
Days Payable 13.53

Financials (Next Earnings Date:2022-11-07)

BSP:B1NT34's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 125,149.562
EPS (TTM) (R$) 278.11
Beta 0
Volatility % 60.37
14-Day RSI 42.98
14-Day ATR (R$) 5.220517
20-Day SMA (R$) 109.7305
12-1 Month Momentum % -61.4
52-Week Range (R$) 76.55 - 303.91
Shares Outstanding (Mil) 242.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioNTech SE Filings

Document Form Filing Date
No Filing Data